Versor Investments LP grew its position in shares of Medical Properties Trust, Inc. (NYSE:MPW – Free Report) by 490.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 97,500 shares of the real estate investment trust’s stock after purchasing an additional 81,000 shares during the quarter. Versor Investments LP’s holdings in Medical Properties Trust were worth $570,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently made changes to their positions in MPW. Wolverine Asset Management LLC lifted its holdings in shares of Medical Properties Trust by 27.8% during the third quarter. Wolverine Asset Management LLC now owns 517,866 shares of the real estate investment trust’s stock worth $3,030,000 after purchasing an additional 112,721 shares during the period. CWA Asset Management Group LLC bought a new stake in Medical Properties Trust in the third quarter valued at approximately $878,000. Sittner & Nelson LLC acquired a new stake in Medical Properties Trust during the 3rd quarter valued at approximately $234,000. Jmac Enterprises LLC acquired a new stake in shares of Medical Properties Trust during the third quarter worth $70,000. Finally, KG&L Capital Management LLC increased its position in shares of Medical Properties Trust by 5.3% during the third quarter. KG&L Capital Management LLC now owns 50,875 shares of the real estate investment trust’s stock worth $298,000 after buying an additional 2,550 shares during the period. 71.79% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other news, Director Elizabeth N. Pitman bought 8,087 shares of the stock in a transaction dated Wednesday, September 18th. The stock was bought at an average price of $6.01 per share, for a total transaction of $48,602.87. Following the completion of the acquisition, the director now directly owns 76,740 shares in the company, valued at approximately $461,207.40. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other Medical Properties Trust news, Director Elizabeth N. Pitman purchased 8,087 shares of the firm’s stock in a transaction that occurred on Wednesday, September 18th. The stock was bought at an average cost of $6.01 per share, with a total value of $48,602.87. Following the completion of the transaction, the director now owns 76,740 shares of the company’s stock, valued at $461,207.40. The trade was a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Michael G. Stewart sold 32,780 shares of Medical Properties Trust stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $5.46, for a total value of $178,978.80. Following the sale, the director now owns 221,245 shares in the company, valued at $1,207,997.70. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.53% of the company’s stock.
Medical Properties Trust Price Performance
Medical Properties Trust Cuts Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, October 10th. Shareholders of record on Monday, September 9th were paid a dividend of $0.08 per share. This represents a $0.32 annualized dividend and a yield of 7.27%. The ex-dividend date of this dividend was Monday, September 9th. Medical Properties Trust’s dividend payout ratio (DPR) is presently -7.58%.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on the company. Truist Financial lifted their price objective on Medical Properties Trust from $5.00 to $6.00 and gave the stock a “hold” rating in a research report on Friday, September 13th. Colliers Securities raised shares of Medical Properties Trust from a “neutral” rating to a “buy” rating and set a $6.50 price objective for the company in a research report on Friday, September 13th. Finally, Wolfe Research raised shares of Medical Properties Trust to a “hold” rating in a research note on Monday, September 23rd. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $5.50.
Check Out Our Latest Analysis on Medical Properties Trust
Medical Properties Trust Profile
Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.
Read More
- Five stocks we like better than Medical Properties Trust
- What Are Dividend Achievers? An Introduction
- Rocket Lab is the Right Stock for the Right Time
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Best Aerospace Stocks Investing
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.